sr 202 (Bio-Techne corporation)
Structured Review
Sr 202, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 352 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sr+202/SR+202/custom%402022%4041248788
Average 90 stars, based on 352 article reviews
Images
Related Articles
Oligomer Restriction:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Concentration Assay:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Enzyme-linked Immunosorbent Assay:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Activity Assay:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Chloramphenicol Acetyltransferase Assay:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Analysis:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Generated:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Expressing:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. Cell Culture:Article Title: Pharmacological inhibition of REV-ERBα ameliorates motor deficits in the 6-OHDA-lesioned mouse model of Parkinson’s disease Article Snippet: ght conditions. The timing of drug administration relative to behavioral testing and general animal handling procedures were adapted from a previously established protocol (Kim, et al. |

![Diverse roles of exosomal non-coding RNAs. Exosomal miRNAs play important roles in cancer <t>progression/metastasis</t> [ , , , , , , ], immune suppression , and M2 macrophages polarization . Hollow arrows denote the direction of the reaction. ↓ denotes decreased expression/activity. ↑ denotes increased expression/activity. CAF denotes cancer-associated fibroblasts.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3086/pmc10223086/pmc10223086__pharmaceutics-15-01465-g003.jpg)